These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35605096)

  • 21. Histone deacetylase inhibitors suppress coxsackievirus B3 growth in vitro and myocarditis induced in mice.
    Shim SH; Park JH; Ye MB; Nam JH
    Acta Virol; 2013; 57(4):462-6. PubMed ID: 24294962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coxsackievirus B3 infects and disrupts human induced-pluripotent stem cell derived brain-like endothelial cells.
    Mamana J; Humber GM; Espinal ER; Seo S; Vollmuth N; Sin J; Kim BJ
    Front Cell Infect Microbiol; 2023; 13():1171275. PubMed ID: 37139492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
    Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X
    Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of prophylactically applied CpG ODN on the development of myocarditis in mice infected with Coxsackievirus B3.
    Zhao T; Wu X; Song D; Fang M; Guo S; Zhang P; Wang L; Wang L; Yu Y
    Int Immunopharmacol; 2012 Dec; 14(4):665-73. PubMed ID: 23063973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent.
    Esfandiarei M; Luo H; Yanagawa B; Suarez A; Dabiri D; Zhang J; McManus BM
    J Virol; 2004 Apr; 78(8):4289-98. PubMed ID: 15047842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular Protein HuR Regulates the Switching of Genomic RNA Templates for Differential Functions during the Coxsackievirus B3 Life Cycle.
    George B; Dave P; Rani P; Behera P; Das S
    J Virol; 2021 Oct; 95(21):e0091521. PubMed ID: 34406862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lncRNA MEG3/miRNA-21/P38MAPK axis inhibits coxsackievirus 3 replication in acute viral myocarditis.
    He F; Liu Z; Feng M; Xiao Z; Yi X; Wu J; Liu Z; Wang G; Li L; Yao H
    Virus Res; 2024 Jan; 339():199250. PubMed ID: 37865350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
    Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
    Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H
    Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual roles of calpain in facilitating Coxsackievirus B3 replication and prompting inflammation in acute myocarditis.
    Li M; Su Y; Yu Y; Yu Y; Wang X; Zou Y; Ge J; Chen R
    Int J Cardiol; 2016 Oct; 221():1123-31. PubMed ID: 27472894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication.
    Qiu Y; Ye X; Zhang HM; Hanson P; Zhao G; Tong L; Xie R; Yang D
    PLoS Pathog; 2017 Dec; 13(12):e1006744. PubMed ID: 29220410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MCPIP1 inhibits coxsackievirus B3 replication by targeting viral RNA and negatively regulates virus-induced inflammation.
    Li M; Yan K; Wei L; Yang Y; Qian Q; Xu W
    Med Microbiol Immunol; 2018 Feb; 207(1):27-38. PubMed ID: 29043433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baicalin Inhibits Coxsackievirus B3 Replication by Reducing Cellular Lipid Synthesis.
    Wang MJ; Yang CH; Jin Y; Wan CB; Qian WH; Xing F; Li X; Liu YY
    Am J Chin Med; 2020; 48(1):143-160. PubMed ID: 31903780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis.
    Van Linthout S; Savvatis K; Miteva K; Peng J; Ringe J; Warstat K; Schmidt-Lucke C; Sittinger M; Schultheiss HP; Tschöpe C
    Eur Heart J; 2011 Sep; 32(17):2168-78. PubMed ID: 21183501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
    Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
    Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anisomycin inhibits Coxsackievirus B replication by promoting the lysosomal degradation of eEF1A1.
    Shao E; Zhao S; Dong Y; Wang Y; Fei Y; Li S; Wang L; Bashir T; Luan T; Lin L; Wang Y; Zhao W; Zhong Z
    Antiviral Res; 2023 Jul; 215():105621. PubMed ID: 37156267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-203 enhances coxsackievirus B3 replication through targeting zinc finger protein-148.
    Hemida MG; Ye X; Zhang HM; Hanson PJ; Liu Z; McManus BM; Yang D
    Cell Mol Life Sci; 2013 Jan; 70(2):277-91. PubMed ID: 22842794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Kidnapping Story: How Coxsackievirus B3 and Its Host Cell Interact.
    Peischard S; Ho HT; Theiss C; Strutz-Seebohm N; Seebohm G
    Cell Physiol Biochem; 2019; 53(1):121-140. PubMed ID: 31230428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver X receptor activation enhances CVB3 viral replication during myocarditis by stimulating lipogenesis.
    Papageorgiou AP; Heggermont W; Rienks M; Carai P; Langouche L; Verhesen W; De Boer RA; Heymans S
    Cardiovasc Res; 2015 Jul; 107(1):78-88. PubMed ID: 25998987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific Bacterial Cell Wall Components Influence the Stability of Coxsackievirus B3.
    Dhalech AH; Fuller TD; Robinson CM
    J Virol; 2021 Oct; 95(22):e0142421. PubMed ID: 34431699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.